PathAI
Boston, Massachusetts, United States · Artificial Intelligence, Biotechnology, Health Care
PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of patient samples to improve efficiency and accuracy of patholo
Key facts
- Headquarters
- Boston, Massachusetts, United States
- Employees
- 280
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- pathai.com
- Company page
Recent activity at PathAI
PathAI funding history
| Date | Round | Amount |
|---|---|---|
| Apr 2019 | Venture | $60.0M |
| Nov 2017 | Venture | $14.9M |
Leadership
- Andy Beck, Executive Officer, Director
- Aditya Khosla, Executive Officer, Director
- Andrew Beck, Executive Officer, Director
- Brandon Eldredge, Chief Financial Officer
Verified email and direct lines for PathAI’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
PathAI files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
PathAI in the news
- PathAI and A.C.Camargo Cancer Center Announce Cooperation to Expand Digital Pathology with AI in Brazil via SUS - GlobeNewswire (May 05, 2026)
- Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics - Fierce Biotech (May 07, 2026)
- Roche to buy PathAI for $750 million - STAT (May 08, 2026)
- Roche acquires PathAI to transform AI-driven diagnostics - MedTech Intelligence (May 11, 2026)
- Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools - WSJ (May 07, 2026)
- DHN - Roche to Acquire PathAI in $1.05 Bn AI Pathology Expansion - Digital Health News (May 11, 2026)
- PathAI and MedStar Health Announce Partnership to Deploy - GlobeNewswire (Apr 07, 2026)
- Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen - The American Journal of Managed Care (Nov 11, 2025)
Companies similar to PathAI
- Blackford Analysis · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Information Technology, Machine Learning
- AKASA · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Information Technology, Machine Learning
- UCANACT · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Information Technology, Machine Learning
- RapidAI · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Information Technology, Machine Learning
- RADPAIR · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Information Technology, Machine Learning
About PathAI: questions and answers
What does PathAI do?
PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of patient samples to improve efficiency and accuracy of patholo
Where is PathAI headquartered?
PathAI is headquartered in Boston, Massachusetts, United States.
How many employees does PathAI have?
PathAI has about 280 employees.
Has PathAI raised funding?
Yes. Fundz has recorded 2 funding events for PathAI. The most recent, $60.0M, was in Apr 2019.
What is the latest news on PathAI?
On May 17, 2026, Roche Acquires PathAI for Up to $1.05 Billion to Enhance Digital Diagnostics in Healthcare.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy